Deutsche Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07B Sell
9,531,362
-598,352
-6% -$133M 0.68% 19
2025
Q4
$2.31B Buy
10,129,714
+673,682
+7% +$153M 0.75% 16
2025
Q3
$2.19B Buy
9,456,032
+274,505
+3% +$55.9M 0.73% 16
2025
Q2
$1.7B Sell
9,181,527
-44,687
-0.5% -$8.31M 0.63% 17
2025
Q1
$1.93B Sell
9,226,214
-542,888
-6% -$106M 0.77% 16
2024
Q4
$1.74B Buy
9,769,102
+2,102,273
+27% +$387M 0.68% 16
2024
Q3
$1.51B Sell
7,666,829
-238,951
-3% -$44.6M 0.62% 21
2024
Q2
$1.36B Sell
7,905,780
-481,517
-6% -$79.8M 0.61% 20
2024
Q1
$1.53B Buy
8,387,297
+1,141,793
+16% +$197M 0.71% 16
2023
Q4
$1.12B Buy
7,245,504
+2,370,693
+49% +$346M 0.57% 24
2023
Q3
$727M Sell
4,874,811
-1,219,010
-20% -$179M 0.47% 39
2023
Q2
$821M Buy
6,093,821
+525,570
+9% +$77.1M 0.44% 38
2023
Q1
$887M Sell
5,568,251
-260,656
-4% -$39.8M 0.49% 36
2022
Q4
$942M Buy
5,828,907
+40,387
+0.7% +$6.19M 0.54% 31
2022
Q3
$777M Sell
5,788,520
-827,922
-13% -$119M 0.47% 40
2022
Q2
$1.01B Buy
6,616,442
+1,198,823
+22% +$183M 0.57% 32
2022
Q1
$878M Sell
5,417,619
-736,561
-12% -$107M 0.41% 46
2021
Q4
$833M Buy
6,154,180
+45,691
+0.7% +$5.4M 0.37% 52
2021
Q3
$659M Sell
6,108,489
-700,907
-10% -$80.1M 0.31% 64
2021
Q2
$767M Buy
6,809,396
+408,252
+6% +$46M 0.37% 49
2021
Q1
$693M Sell
6,401,144
-2,075,861
-24% -$222M 0.37% 50
2020
Q4
$908M Sell
8,477,005
-3,507,205
-29% -$337M 0.55% 32
2020
Q3
$1.05B Buy
11,984,210
+3,429,344
+40% +$323M 0.72% 25
2020
Q2
$840M Buy
8,554,866
+383,081
+5% +$33.7M 0.64% 29
2020
Q1
$623M Buy
8,171,785
+895,838
+12% +$76.3M 0.56% 35
2019
Q4
$644M Sell
7,275,947
-855,113
-11% -$71M 0.42% 45
2019
Q3
$616M Buy
8,131,060
+45,949
+0.6% +$3.15M 0.43% 47
2019
Q2
$588M Buy
8,085,111
+633,773
+9% +$49.8M 0.35% 57
2019
Q1
$600M Buy
7,451,338
+2,253,595
+43% +$184M 0.36% 55
2018
Q4
$479M Sell
5,197,743
-1,469,781
-22% -$129M 0.34% 56
2018
Q3
$631M Sell
6,667,524
-1,318,824
-17% -$125M 0.32% 55
2018
Q2
$740M Sell
7,986,348
-2,185,643
-21% -$213M 0.37% 46
2018
Q1
$963M Buy
10,171,991
+6,007,655
+144% +$660M 0.46% 39
2017
Q4
$403M Sell
4,164,336
-427,537
-9% -$40.3M 0.26% 82
2017
Q3
$408M Sell
4,591,873
-1,428,337
-24% -$109M 0.28% 70
2017
Q2
$437M Sell
6,020,210
-761,381
-11% -$51.2M 0.31% 62
2017
Q1
$442M Sell
6,781,591
-34,925
-0.5% -$2.2M 0.33% 65
2016
Q4
$427M Sell
6,816,516
-2,027,823
-23% -$124M 0.34% 57
2016
Q3
$558M Sell
8,844,339
-108,541
-1% -$7.03M 0.39% 49
2016
Q2
$554M Buy
8,952,880
+372,734
+4% +$22.7M 0.39% 49
2016
Q1
$490M Sell
8,580,146
-124,651
-1% -$6.95M 0.37% 56
2015
Q4
$516M Buy
8,704,797
+2,181,486
+33% +$126M 0.36% 52
2015
Q3
$355M Buy
6,523,311
+672,937
+12% +$43.8M 0.27% 72
2015
Q2
$393M Buy
5,850,374
+322,500
+6% +$21.1M 0.25% 82
2015
Q1
$324M Buy
5,527,874
+1,371,094
+33% +$82.8M 0.2% 115
2014
Q4
$272M Sell
4,156,780
-4,412,198
-51% -$278M 0.17% 139
2014
Q3
$495M Buy
8,568,978
+3,970,664
+86% +$220M 0.31% 61
2014
Q2
$260M Sell
4,598,314
-119,132
-3% -$6.25M 0.18% 122
2014
Q1
$242M Sell
4,717,446
-997,271
-17% -$50.4M 0.17% 133
2013
Q4
$302M Sell
5,714,717
-272,212
-5% -$13.4M 0.22% 101
2013
Q3
$268M Buy
5,986,929
+667,989
+13% +$29.6M 0.2% 106
2013
Q2
$220M Buy
+5,318,940
New +$233M 0.18% 121

Other funds holding ABBV

Deutsche Bank's ABBV Position: Q1 2026 in Review

Deutsche Bank reduced its AbbVie (ABBV) stake by 5.9% in Q1 2026, selling an estimated $133M and leaving 9,531,362 shares worth $2.07B. The position accounts for 0.68% of the portfolio, ranked #19.

Deutsche Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.31B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Deutsche Bank held 9,531,362 shares of AbbVie worth $2.07B as of Q1 2026.
  • Deutsche Bank sold 598,352 AbbVie shares in Q1 2026, an estimated $133M.
  • AbbVie made up 0.68% of Deutsche Bank's portfolio in Q1 2026, its #19 holding.
  • Deutsche Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's AbbVie position peaked at $2.31B in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.